Oxford Immunotec (OXFD) Tops Q1 EPS by 5c, Beats on Revenues

Oxford Immunotec (NASDAQ: OXFD) reported Q1 EPS of ($0.40), $0.05 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $21.4 million versus the consensus estimate of $20.96 million.

GUIDANCE:

Oxford Immunotec sees FY2018 revenue of $112-115 million.

For earnings history and earnings-related data on Oxford Immunotec (OXFD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Movano (MOVE) Misses Q2 EPS by 195c